Evidence map›Paper›PMID 39139324›Full record

ArticleCureus2024

Unplanned 30-Day Readmissions After Hospitalization for Irritable Bowel Syndrome.

Joshua O Ugboke, Fidelis Uwumiro, Efeturi M Okorigba, Ridwan A Lawal, Victory Okpujie, Chukwunonso Ndulue, Love O Temple-Obi, Emmanuel I Bassey, Abdulraheem E Hassan, Sara Ozumba

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Joshua O UgbokeInternal Medicine, College of Medicine, University of Lagos, Lagos, NGA.
Fidelis UwumiroInternal Medicine, Our Lady of Apostles Hospital, Akwanga, NGA.
Efeturi M OkorigbaInternal Medicine, College of Medicine, University of Lagos, Lagos, NGA.
Ridwan A LawalInternal Medicine, College of Medicine, University of Lagos, Lagos, NGA.
Victory OkpujieInternal Medicine, Central Hospital Benin, Benin City, NGA.
Chukwunonso NdulueInternal Medicine, College of Medicine, University of Lagos, Lagos, NGA.
Love O Temple-ObiInternal Medicine, University of Abuja Teaching Hospital, Gwagwalada, NGA.
Emmanuel I BasseyInternal Medicine, College of Health Sciences, University of Uyo, Uyo, NGA.
Abdulraheem E HassanInternal Medicine, College of Medicine, University of Lagos, Lagos, NGA.
Sara OzumbaFamily Medicine, University of Nigeria, Enugu, NGA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Irritable bowel syndrome (IBS) continues to pose significant healthcare challenges due to its broad differential diagnosis and the often extensive yet inconclusive workup. We investigated the rates and characteristics of unplanned 30-day readmissions in adult patients hospitalized with IBS. In addition, we identified factors that predict readmission within 30 days of initial discharge. Methods We analyzed the 2020 Nationwide Readmission Database. Using the International Classification of Diseases, Tenth Revision, Clinical Modification code, we identified hospitalizations in adult patients with IBS. We excluded hospitalizations for minors and planned or elective readmissions. To compare baseline characteristics between readmissions and index hospitalizations, χ2 tests were employed. We used multivariate Cox regression analyses to identify independent predictors of readmissions. Results A total of 5,729 adult hospitalizations with IBS as the primary diagnosis were discharged alive, and 638 (11.1%) readmissions occurred within 30 days. The most common diagnoses associated with readmission were noninfective gastroenteritis and colitis, sepsis, enterocolitis due to

Indexed as

30-day readmissionshospital resource utilizationibs (irritable bowel syndrome)irritable bowel diseasenationwide readmissions database

Identifiers

PMID39139324
PMCPMC11321272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.